Study of Y-6 tablets for acute large vessel stroke
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests whether a new tablet (Y-6) given under the tongue can improve recovery after a severe stroke caused by a blocked large blood vessel in the brain. The study is for people who are already scheduled to have a procedure to remove the blockage.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 35 and 80 years old.
- Your stroke began within the last 24 hours.
- You have not had a stroke before, or you had no disability before this stroke.
- Imaging shows a blockage in a large blood vessel in the front part of your brain.
- You have moderate to severe stroke symptoms (but not the most severe level).
- You are planned to have a procedure to remove the blockage (endovascular treatment).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new tablet that dissolves under the tongue to help people who just had a small stroke in the deep parts of the brain. The tablet might help improve recovery by reducing damage from the stroke.
This trial tests an investigational drug called B2065 for people who have had a recent ischemic stroke (a stroke caused by a blockage in a blood vessel in the brain). The goal is to see if it is safe and if it might help improve recovery when given within 36 hours of stroke symptoms starting.
This trial tests whether MT200605 can help people who recently had an ischemic stroke (a type of stroke caused by a blocked blood vessel). The drug is given within 24 hours of symptoms starting, and you may join even if you received clot-busting treatment already.
This study tests whether a medication called a GLP-1 receptor agonist (a type of drug used for diabetes) can improve recovery after a major stroke that was treated with a procedure to remove the blood clot. The goal is to see if this drug helps reduce further brain damage and improve outcomes.
This trial tests a new approach to restore blood flow in the brain after a stroke. It aims to improve recovery and brain function in people with a blocked large artery.
This trial tests if a procedure to remove a large blood clot from the brain (called a thrombectomy) can help people with severe strokes who have a large damaged area. It is for people who can be treated within 24 hours of their stroke starting.
Hear when a new Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.